Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-27921

Single-particle
3.1 Å
EMD-27921
3D View Gallery
Deposition: 22/08/2022
Map released: 09/08/2023
Last modified: 09/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-27921
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 8e6k summary report (pdf.gz) Map and 8e6k FULL report (pdf.gz)
EMICSS annotations (xml)

2H08 Fab in complex with influenza virus neuraminidase from A/Brevig Mission/1/1918 (H1N1)

EMD-27921

Single-particle
3.1 Å
EMD-27921
3D View Gallery
Deposition: 22/08/2022
Map released: 09/08/2023
Last modified: 09/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Influenza A virus (A/Brevig Mission/1/1918(H1N1)), Homo sapiens
Sample: 2H08 Fab in complex with influenza virus neuraminidase from A/Brevig Mission/1/1918 (H1N1)
Fitted models: 8e6k

Deposition Authors: Turner HL, Ozorowski G, Ward AB
Human anti-N1 monoclonal antibodies elicited by pandemic H1N1 virus infection broadly inhibit HxN1 viruses in vitro and in vivo.
Hansen L, McMahon M, Turner HL, Zhu X, Turner JS, Ozorowski G, Stadlbauer D, Vahokoski J, Schmitz AJ, Rizk AA, Alsoussi WB, Strohmeier S, Yu W, Choreno-Parra JA, Jimenez-Alvarez L, Cruz-Lagunas A, Zuniga J, Mudd PA, Cox RJ, Wilson IA, Ward AB, Ellebedy AH, Krammer F
(2023) Immunity , 56 , 1927 - 1938.e8
PUBMED: 37506693
DOI: doi:10.1016/j.immuni.2023.07.004
ISSN: 1074-7613
ASTM: IUNIEH